ட்ரெவர் ஹலாம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ட்ரெவர் ஹலாம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ட்ரெவர் ஹலாம் Today - Breaking & Trending Today

Sutro Biopharma Announces Expansion of Leadership Team

Sutro Biopharma Announces Expansion of Leadership Team
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Stanford University , United States , South San Francisco , Palo Alto , Trevor Hallam , Maggie Beller , Werner Rubas , Sutro Xpress , Nicolem Chieffo , Sutro Biopharma , Anniej Chang , Arturo Molina , Nicole Chieffo , Celgene Corporation , Adamantech Inc , Global Clinical Development Teams , Merck Kga , Clinical Research , Bristol Myers Squibb , Amylin Pharmaceuticals , Stage Research , Preclinical Development , Nektar Therapeutics , Response Corporation , School Of Pharmacy , Master In Business Administration ,

Sutro Biopharma Earns Milestone Payment from Bispecific Antibody-Drug Conjugate Collaboration with Merck KGaA, Darmstadt, Germany

/PRNewswire/ Sutro Biopharma, Inc. (NASDAQ: STRO), clinical-stage drug discovery, development and manufacturing company focused on the application of. ....

Sutro Biopharma , Trevor Hallam , Maggie Beller , Anniej Chang , Sutro Xpress , Celgene Corporation , Exchange Commission , Prnewswire Sutro Biopharma Inc , Merck Kga , Sutro Biopharma Inc , Merck Kgaa , Bristol Myers Squibb , Bill Newell , Chief Executive Officer , Chief Scientific Officer , South San Francisco , Orphan Drug Designation , Myers Squibb , Darmstadt Germany , Private Securities Litigation Reform Act , ட்ரெவர் ஹலாம் , மாகி பெல்லர் , சூட்ரோ க்ஸ்ப்ரெஸ் , செல்ஜீன் நிறுவனம் , பரிமாற்றம் தரகு , மெர்க் க்க ,

Sutro Biopharma Promotes Trevor Hallam, Ph.D., to President of Research and Chief Scientific Officer

Share this article
Share this article
SOUTH SAN FRANCISCO, Calif., April 20, 2021 /PRNewswire/ Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation cancer and autoimmune therapeutics, today announced the promotion of Chief Scientific Officer Trevor Hallam, Ph.D., to President of Research. Dr. Hallam will also continue his role as Chief Scientific Officer.
Since joining Sutro as CSO more than 10 years ago, Trevor has been instrumental in the development of our cell-free protein synthesis platform from a novel but immature technology to a robust multi-modality platform with a proven manufacturing capability. Additionally, Trevor conceived of and drove our vision to initially focus the platform on antibody drug conjugates (ADCs). Using Sutro s platform for ADCs captures the advantages and power of our propriet ....

United Kingdom , Rhone Poulenc Rorer , Sutro Biopharma , Trevor Hallam , Maggie Beller , Anniej Chang , Connie Matsui , Sutro Xpress , Physiological Laboratory , Celgene Corporation , Smithkline French Laboratories Ltd , University Of Cambridge , Merck Kga , Bristol Myers Squibb , Glaxo Group Research Ltd , Kings College , Roche Research , Exchange Commission , University Of London , Sutro Biopharma Inc , Merck Kgaa , University Of Leeds , Research Development At Palatin Technologies Inc , Chief Scientific Officer Trevor Hallam , Chief Scientific , Using Sutro ,